Study to Evaluate the Immunogenicity and Safety of LBVD (Hexavalent Vaccine; DTwP-HepB-IPV-Hib Vaccine), Given to Healthy Infants at Primary Series
Conditions: Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type B Infection Interventions: Biological: LBVD (Hexavalent vaccine); Biological: Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) Sponsor: LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials